Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2023

Caitlin E. Cox

December 28, 2023

News Daily News

Jean-Philippe Collet, Thrombosis Expert and Trialist, Dies at 59

Yael L. Maxwell

December 18, 2023

News Daily News

‘Total Ischemic Time’ Key to Cutting NSTEMI Deaths With Invasive Strategy

Yael L. Maxwell

January 11, 2023

Presentation TCT 2022

Does Bleeding Risk Outweigh Thrombotic Risk or Vice Versa?

Presenter: Jean-Philippe Collet

September 18, 2022

Podcast TCTMD Talking Points

The ATLANTIS Trial: DOACs in TAVI?

February 02, 2022

News Conference News

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Shelley Wood

August 30, 2021

News Conference News ACC 2021

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

Yael L. Maxwell

May 15, 2021

News Daily News

Experts Update Antithrombotic Advice in AF Patients Undergoing PCI

Todd Neale

February 09, 2021

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Daily News

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Yael L. Maxwell

October 16, 2019

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Conference News ESC 2016

Screening for and Treating Asymptomatic Extracoronary Disease No Help in High-risk CAD

Todd Neale

August 29, 2016

News Daily News

Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI

L.A. McKeown

August 17, 2016

News Daily News

Ausencia de Datos: No Sabemos Cuál es la Mejor Estrategia para el Manejo de Pacientes con FA a Tratamiento con los Últimos Anticoagulantes y que Necesitan una PCI

L.A. McKeown

August 17, 2016

Presentation TCT 2013

ARCTIC-INTERRUPTION: A Prospective, Randomized Trial of Two Years vs. One Year of Dual Antiplatelet Therapy After PCI

Presenter: Jean-Philippe Collet

October 31, 2013

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2023

Jean-Philippe Collet, Thrombosis Expert and Trialist, Dies at 59

‘Total Ischemic Time’ Key to Cutting NSTEMI Deaths With Invasive Strategy

Does Bleeding Risk Outweigh Thrombotic Risk or Vice Versa?

The ATLANTIS Trial: DOACs in TAVI?

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

Experts Update Antithrombotic Advice in AF Patients Undergoing PCI

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Screening for and Treating Asymptomatic Extracoronary Disease No Help in High-risk CAD

Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI

Ausencia de Datos: No Sabemos Cuál es la Mejor Estrategia para el Manejo de Pacientes con FA a Tratamiento con los Últimos Anticoagulantes y que Necesitan una PCI

ARCTIC-INTERRUPTION: A Prospective, Randomized Trial of Two Years vs. One Year of Dual Antiplatelet Therapy After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content